Alerts will be sent to your verified email
Verify Email
ISHITADR
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
Hamps Bio
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.38 % | -46.46 % | 14.19 % |
|
5yr average Equity Multiplier
|
1.27 | 0.08 | 2.36 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 0.14 | 1.18 |
|
5yr Avg Net Profit Margin
|
5.43 % | -19.62 % | 5.23 % |
|
Price to Book
|
1.96 | 2.33 | 2.16 |
|
P/E
|
22.19 | 59.46 | 63.42 |
|
5yr Avg Cash Conversion Cycle
|
74.52 Days | 288.55 Days | 74.76 Days |
|
Inventory Days
|
35.08 Days | 5.2 Days | 53.3 Days |
|
Days Receivable
|
31.6 Days | 430.69 Days | 59.7 Days |
|
Days Payable
|
42.7 Days | 141.12 Days | 80.45 Days |
|
5yr Average Interest Coverage Ratio
|
24.46 | -260.56 | 3.45 |
|
5yr Avg ROCE
|
11.48 % | -47.43 % | 18.02 % |
|
5yr Avg Operating Profit Margin
|
6.66 % | -65.91 % | 14.19 % |
|
5 yr average Debt to Equity
|
0.09 | -0.45 | 0.99 |
|
5yr CAGR Net Profit
|
0.95 % | -42.57 % | 20.11 % |
|
5yr Average Return on Assets
|
6.68 % | 199.45 % | 6.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.96 % | 23.13 % | 71.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.64 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
Hamps Bio
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|